Episode 60: John Vandermosten

Episode 60: John Vandermosten

Desde: CEO Money
de RNCN
0 0 hace 6 meses
John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small cap biotechnology names. His background includes 15 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure.

Formerly, John was a research analyst for Singular Research covering the health care space and a consultant with Coker Group, a national healthcare services firm ... Más informaciones

Autor

Síguenos en Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Help